ORG Partners LLC Acquires 70 Shares of Cigna Group $CI

ORG Partners LLC boosted its holdings in shares of Cigna Group (NYSE:CI) by 4.6% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 1,581 shares of the health services provider’s stock after buying an additional 70 shares during the quarter. ORG Partners LLC’s holdings in Cigna Group were worth $529,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in CI. Cove Private Wealth LLC boosted its position in shares of Cigna Group by 6.2% during the second quarter. Cove Private Wealth LLC now owns 1,540 shares of the health services provider’s stock worth $509,000 after buying an additional 90 shares during the period. Patton Fund Management Inc. purchased a new stake in shares of Cigna Group during the 2nd quarter worth about $217,000. Kathmere Capital Management LLC lifted its stake in shares of Cigna Group by 66.6% in the second quarter. Kathmere Capital Management LLC now owns 1,361 shares of the health services provider’s stock worth $450,000 after acquiring an additional 544 shares in the last quarter. ST Germain D J Co. Inc. raised its holdings in shares of Cigna Group by 830.5% during the second quarter. ST Germain D J Co. Inc. now owns 4,206 shares of the health services provider’s stock worth $1,390,000 after purchasing an additional 3,754 shares during the period. Finally, Bank Pictet & Cie Europe AG grew its stake in shares of Cigna Group by 11.0% in the second quarter. Bank Pictet & Cie Europe AG now owns 14,309 shares of the health services provider’s stock worth $4,730,000 after purchasing an additional 1,418 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Stock Performance

NYSE:CI opened at $286.04 on Friday. Cigna Group has a 1-year low of $256.89 and a 1-year high of $358.88. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm has a market capitalization of $76.35 billion, a price-to-earnings ratio of 15.61, a PEG ratio of 0.84 and a beta of 0.48. The company’s 50-day moving average is $292.71 and its two-hundred day moving average is $310.50.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating the consensus estimate of $7.15 by $0.05. The business had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter last year, the firm posted $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group’s dividend payout ratio (DPR) is currently 32.97%.

Insider Activity

In other news, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.70% of the stock is owned by insiders.

Analyst Ratings Changes

Several research firms have issued reports on CI. TD Cowen upgraded shares of Cigna Group to a “strong-buy” rating in a research report on Monday, June 23rd. Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the company a “buy” rating in a research report on Tuesday, August 5th. Robert W. Baird set a $372.00 target price on Cigna Group in a research report on Thursday, August 14th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $371.00 price objective on shares of Cigna Group in a report on Thursday, June 26th. Finally, Guggenheim reissued a “buy” rating and issued a $350.00 target price (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $371.81.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.